Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

Impact · against what's priced in

Phio Pharmaceuticals' participation in the Sidoti conference is a non-material event, though the promise of an update on the PH-762 clinical trial creates a potential short-term catalyst. The news itself does not change the company's fundamental valuation but sets a date for potential data volatility.

PHIO+0.10

No priced-in read yet